Koyfin Home > Directory > Health Care > Biogen Inc > EV / EBITDA (ltm)

Biogen Inc EV / EBITDA (ltm) Chart (BIIB)

Biogen Inc annual/quarterly EV / EBITDA (ltm) from 2010 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Biogen Inc EV / EBITDA (ltm) for the quarter ending November 11, 2020 was 5.64 a -1.76% decrease of -0.10 year over year
  • Biogen Inc EV / EBITDA (ltm) for the last 12 months ending November 11, 2020 was 5.64 a -1.76% decrease of -0.10 year over year
  • Biogen Inc Annual EV / EBITDA (ltm) for 2020 was 5.64 a 0.05% increase of 0.00 from 2019
  • Biogen Inc Annual EV / EBITDA (ltm) for 2020 was 5.64 a 1.14% increase of 0.06 from 2019
  • Biogen Inc Annual EV / EBITDA (ltm) for 2020 was 5.58 a -2.99% decrease of -0.17 from 2019
Other Valuation Metrics:
  • Biogen Inc Market Cap for the quarter ending June 06, 2018 was $61,243m a -8.10% decrease of -4,961m year over year
  • Biogen Inc Price / Book for the quarter ending June 06, 2018 was 4.36 a -31.13% decrease of -1.36 year over year
  • Biogen Inc Enterprise Value for the quarter ending March 03, 2018 was $60,165m a -2.37% decrease of -1,425m year over year
View Chart On Koyfin

Quarterly BIIB EV / EBITDA (ltm) Data

11/20205.64
11/20205.64
11/20205.58
11/20205.74
11/20205.79
11/20205.74
11/20205.59
11/20205.64
11/20205.48
11/20205.48

Annual BIIB EV / EBITDA (ltm) Data

20205.64
20205.64
20205.58
20205.74
20205.79
20205.74
20205.59
20205.64
20205.48
20205.48